Metolazone: Clinical Trials

26 trials of Metolazone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 5 terminated, 4 recruiting, 4 unknown. 8 Phase 4, 6 Not applicable, 5 Phase 2, 4 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 48Terminated 4, Completed 1, Recruiting 1, Suspended 1, Unknown 1
Not applicable6Withdrawn 3, Completed 1, Not yet recruiting 1, Recruiting 1
Phase 25Recruiting 2, Terminated 1, Unknown 1, Withdrawn 1
Phase 14Completed 4
Phase 32Unknown 2

Follow Metolazone: new trials by email Literature Review of Metolazone trials Research Report on Metolazone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Add-on Diuretics in Acute Decompensated Heart Failure
empagliflozin, Acetazolamide, metolazone - Acute Decompensated Heart Failure
Phase 2RecruitingTanta University662026-02-012026-02-04
Comparative Efficacy and Safety of Acetazolamide Versus Metolazone as an Adjunct to Standard Therapy in Patients With Acute Decompensated Heart Failure
Acetazolamide, Metolazone - Acute Decompensated Heart Failure, Heart Failure, Diastolic
Not applicableRecruitingUniversity of Health Sciences Lahore3202025-10-112025-10-03
Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload
Acetazolamide, Metolazone 2.5 MG, Double-placebo - Acute Heart Failure
Phase 4RecruitingJohannes Grand9392024-09-052026-08-14
Efficacy and Safety of Combination Diuretic Therapy in Patients With Acute Decompensated Heart Failure and Volume Overload
Acetazolamide, Metolazone, IV Loop Diuretics - Acute Decompensated Heart Failure, Volume Overload
Phase 4UnknownCairo University1102024-07-012024-07-24
Role of Active Deresuscitation After Resuscitation:
Furosemide Injection, Metolazone Tablets - Fluid Overload, Critical Illness
Phase 2UnknownUnity Health Toronto1202024-05-012024-03-22
Acetazolamide or Metolazone in Acute Heart Failure
Acetazolamide 250 MG, Metolazone 2.5 MG, Furosemide Injection - Heart Failure Acute, Decompensated Heart Failure
Not applicableNot yet recruitingClinica Alemana de Santiago10502024-05-012024-03-18
Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic Resistance
Furosemide, Metolazone, Acetazolamide - Acute Heart Failure, Diuretic Resistance
Phase 4TerminatedStadtspital Zürich132023-10-102025-02-14
DAPAgliflozin Versus Thiazide Diuretic in Patients With Heart Failure and Diuretic RESISTance
Dapagliflozin 10 MG Oral Tablet, Metolazone Tablets - Heart Failure
Phase 3UnknownNHS Greater Glasgow and Clyde612021-04-272023-04-10
Ertugliflozin in Chronic Heart Failure
Ertugliflozin, Metolazone, Placebo - Heart Failure
Phase 2RecruitingYale University602021-03-102025-10-08
Efficacy of Diuretics in Kidney Disease
Metolazone, Placebo - Chronic Kidney Disease, End Stage Renal Disease
Phase 2TerminatedStanford University172021-03-012025-06-05
Coronavirus (COVID-19) ACEi/ARB Investigation
Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor - Hypertension, COVID-19
Phase 4SuspendedNational University of Ireland, Galway, Ireland24142020-04-302020-06-30
ACEI or ARB and COVID-19 Severity and Mortality in US Veterans
ACEI/ARB, Non-ACEI/ARB, ACEI - Hypertension, COVID
CompletedUniversity of Utah222132020-01-192021-04-28
Sequential Nephron Blockade in Acute Heart Failure
Metolazone, Loop Diuretics - Acute Heart Failure
Phase 3UnknownPoliclinico Casilino ASL RMB3102019-10-012019-11-19
Diuretic Effect of Metolazone Pre-dosing Versus Concurrent Dosing
Metolazone 60 minutes prior to furosemide, Metolazone concurrently with furosemide - Fluid Overload, Heart Failure Acute
Phase 4TerminatedUniversity of Maryland, Baltimore32019-01-012021-10-22
Prospective Comparison of Metolazone Versus Chlorothiazide for Acute Decompensated Heart Failure With Diuretic Resistance
Metolazone Oral Tablet, Chlorothiazide Injection - Heart Failure, Heart Failure With Reduced Ejection Fraction
Phase 4TerminatedUniversity of Virginia52018-06-012021-02-16
Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure
tolvaptan, Chlorothiazide, Metolazone - Heart Failure
Phase 4CompletedVanderbilt University602016-02-012019-11-08
AiDing Diuresis wIth Tolvaptan (ADD-IT)
Tolvaptan 30 mg + IV Diuretics, Metolazone 5 mg + IV Diuretics, 2.5 times the Diuretics Dose - Cardiomyopathy, Congestive Heart Failure
Phase 1CompletedEmory University142016-01-012019-03-27
Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure
Placebo, Metolazone - Acute Decompensated Heart Failure
Phase 2WithdrawnScripps Health2014-03-012022-12-01
A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS II)
Furosemide, metolazone, furosemid/spironolactone - Congestive Heart Failure
Not applicableWithdrawnYonsei University2014-01-012016-09-07
A Prospective, Single-center, Open-label, Pilot Study to Compare the Effectiveness and Safety of Diuretics Add-On Strategy in Chronic Heart Failure Patients (DIOS 1)
furosemide/no spironolactone, metolazone/no spironolactone, furosemid/spironolactone - Congestive Heart Failure
Not applicableWithdrawnYonsei University2013-03-012014-02-19

Showing 20 of 26. Sign in to see all of them.

Conditions studied

Heart Failure (8)  ·  Edema (4)  ·  Cardiovascular Diseases (2)  ·  Hypertension (2)  ·  COVID-19 (1)  ·  Cardiomyopathies (1)  ·  Coronavirus Infections (1)  ·  Critical Illness (1)  ·  Heart Failure, Diastolic (1)  ·  Heart Failure, Systolic (1)  ·  Hypernatremia (1)  ·  Kidney Failure, Chronic (1)  ·  Multiple Trauma (1)  ·  Renal Insufficiency, Chronic (1)  ·  Respiratory Distress Syndrome (1)

Sponsors

Mylan Pharmaceuticals Inc (3)  ·  Yonsei University (2)  ·  Cairo University (1)  ·  Clinica Alemana de Santiago (1)  ·  Emory University (1)  ·  Johannes Grand (1)  ·  NHS Greater Glasgow and Clyde (1)  ·  National University of Ireland, Galway, Ireland (1)  ·  Oregon Health and Science University (1)  ·  Policlinico Casilino ASL RMB (1)  ·  Scripps Health (1)  ·  Stadtspital Zürich (1)  ·  Stanford University (1)  ·  Tanta University (1)  ·  Unity Health Toronto (1)

Countries

United States (14)  ·  Egypt (2)  ·  Canada (1)  ·  Denmark (1)  ·  Ireland (1)  ·  Italy (1)  ·  Pakistan (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Adam P Bress, PharmD, MS (1)  ·  Brent Reed, PharmD (1)  ·  Dalia A Gomaa, MSc in clinical pharmacy (1)  ·  Dan Hagg, MS MD (1)  ·  David Steiger, JD MD (1)  ·  Divya Gupta, MD (1)  ·  Dorian Williams, M.D. (1)  ·  Gennaro Cice, MD (1)  ·  James T Heywood, MD (1)  ·  Jeffrey Testani, MD (1)  ·  Jo E. Rodgers, PharmD (1)  ·  Johannes Grand, MD, Phd, MPH (1)  ·  John C Marshall, MD (1)  ·  John McMurray, MBChB (1)  ·  John William McEvoy, MBBCh MHS (1)

Results publications

PMID 31838029, PMID 33891615, PMID 37210742